Robert W Schrier
Overview
Explore the profile of Robert W Schrier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
212
Citations
7787
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Qavi A, Kamal R, Schrier R
Int J Nephrol
. 2015 Aug;
2015:975934.
PMID: 26294976
Diuretics play significant role in pharmacology and treatment options in medicine. This paper aims to review and evaluate the clinical use of diuretics in conditions that lead to fluid overload...
13.
Moore C, Spillane S, Simon G, Maxwell B, Rahbari-Oskoui F, Braun W, et al.
Contemp Clin Trials
. 2015 Aug;
44:48-55.
PMID: 26231556
Background: The HALT Polycystic Kidney Disease Trials Network consisted of two randomized, double blind, placebo-controlled trials among patients with autosomal dominant polycystic kidney disease. The trials involved 5-8years of participant...
14.
Klawitter J, McFann K, Pennington A, Wang W, Klawitter J, Christians U, et al.
Clin J Am Soc Nephrol
. 2015 Jul;
10(9):1534-41.
PMID: 26224879
Background And Objectives: Disease-specific treatment options for autosomal dominant polycystic kidney disease are limited. Clinical intervention early in life is likely to have the greatest effect. In a 3-year randomized...
15.
Perrone R, Neville J, Chapman A, Gitomer B, Miskulin D, Torres V, et al.
Am J Kidney Dis
. 2015 Jun;
66(4):583-90.
PMID: 26088508
Data standards provide a structure for consistent understanding and exchange of data and enable the integration of data across studies for integrated analysis. There is no data standard applicable to...
16.
Chapman A, Devuyst O, Eckardt K, Gansevoort R, Harris T, Horie S, et al.
Kidney Int
. 2015 Mar;
88(1):17-27.
PMID: 25786098
Autosomal-dominant polycystic kidney disease (ADPKD) affects up to 12 million individuals and is the fourth most common cause for renal replacement therapy worldwide. There have been many recent advances in...
17.
18.
Masoumi A, Ortiz F, Radhakrishnan J, Schrier R, Colombo P
Heart Fail Rev
. 2014 Dec;
20(3):283-90.
PMID: 25447845
Despite significant improvements in diagnosis, understanding the pathophysiology and management of the patients with acute decompensated heart failure (ADHF), diuretic resistance, yet to be clearly defined, is a major hurdle....
19.
Schrier R, Abebe K, Perrone R, Torres V, Braun W, Steinman T, et al.
N Engl J Med
. 2014 Nov;
371(24):2255-66.
PMID: 25399733
Background: Hypertension is common in autosomal dominant polycystic kidney disease (ADPKD) and is associated with increased total kidney volume, activation of the renin-angiotensin-aldosterone system, and progression of kidney disease. Methods:...
20.
Torres V, Abebe K, Chapman A, Schrier R, Braun W, Steinman T, et al.
N Engl J Med
. 2014 Nov;
371(24):2267-76.
PMID: 25399731
Background: Hypertension develops early in patients with autosomal dominant polycystic kidney disease (ADPKD) and is associated with disease progression. The renin-angiotensin-aldosterone system (RAAS) is implicated in the pathogenesis of hypertension...